A. Leighton

发表

A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model

S. Ryser, L. Kauvar, Yifan Yang, 2016, Antimicrobial Agents and Chemotherapy.

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

R. Postier, T. Butler, K. Reinhart, 2001, Critical care medicine.

A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections

S. Ryser, L. Kauvar, A. Bayer, 2017, Antimicrobial Agents and Chemotherapy.

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

H. Bruining, T. Butler, K. Kudsk, 1997, JAMA.

Audiologic monitoring for potential ototoxicity in a phase I clinical trial of a new glycopeptide antibiotic.

A. Gottlieb, L. Hughes, M. Dorr, 2003, Journal of the American Academy of Audiology.

p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial

H. Bruining, T. Butler, K. Kudsk, 1997 .

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

T. Butler, K. Kudsk, W. Lesslauer, 2001, Critical care medicine.

Tolerability, Pharmacokinetics, and Serum Bactericidal Activity of Intravenous Dalbavancin in Healthy Volunteers

A. Gottlieb, E. Mroszczak, M. Dorr, 2004, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics and renal excretion of dalbavancin in healthy subjects

A. Gottlieb, M. Cavaleri, M. Dorr, 2002 .

Impact of immunomodulating therapy on morbidity in patients with severe sepsis.

D. Pittet, P. Suter, K. Reinhart, 1999, American journal of respiratory and critical care medicine.

A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections

S. Ryser, L. Kauvar, Y. Xiong, 2017, Antimicrobial Agents and Chemotherapy.